Your child will be diagnosed with a urinary tract infection (an infection affecting the bladder or kidneys) based on a fever of at least 38°C and a positive urine test.

The diagnosis will be confirmed by a urine culture, which is a laboratory test that identifies the bacteria causing the infection.

Your child must be between 3 months and 3 years of age to participate in this trial.

Your child will be randomly assigned to one of two treatment groups. This means that chance will determine which treatment duration your child receives.

One group will receive antibiotic treatment for a shorter duration (24 hours after fever resolves), while the other group will receive the standard 10-day treatment.

Your child will receive amoxicillin and clavulanic acid (brand name Augmentin Fruit) as an oral suspension (liquid medicine taken by mouth).

The dosage is 400 mg/57 mg per 5 ml.

If your child is assigned to the shorter treatment group, the antibiotic will be given until 24 hours after the fever has resolved.

If your child is assigned to the standard treatment group, the antibiotic will be given for a total of 10 days.

The specific frequency of doses will be determined by the treating physician according to standard medical practice.

Your child’s temperature will be monitored to determine when the fever has resolved.

Clinical assessment will be performed to evaluate how your child is responding to the treatment.

After the antibiotic treatment ends, your child will be monitored for 30 days.

During this period, clinical assessments and urine tests will be performed to check for any return of infection symptoms.

If symptoms of urinary tract infection reappear during this time, a urine test and urine culture will be performed to check for infection recurrence.

The main outcome being measured is whether the infection returns within 30 days after treatment ends.

The trial will also evaluate how well the treatment worked in the short term and whether bacteria resistant to the antibiotic have developed.